Karolinska Development
An investment company that finances and supports innovative life science ventures.
KDEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0002190850 (+1 more)
- LEI:
- 54930011ZA52NKO5W681
- Country:
- Sweden
- Address:
- Nanna Svartz väg 6A, 171 65 Solna
Description
Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2011-11-25 00:00 | English | 1.1 MB | |||
| 2011-11-21 10:26 |
Karolinska Development - Delårsrapport januari - september, inbjudan till telef…
|
Swedish | 272.8 KB | ||
| 2011-11-21 10:26 |
Karolinska Development - Interim report January - September, conference call Fr…
|
English | 274.8 KB | ||
| 2011-09-26 14:00 |
Axelar rapporterar bra säkerhetsprofil för AXL1717 i klinisk fas I/II studie i …
|
Swedish | 21.2 KB | ||
| 2011-09-26 14:00 |
Axelar reports good safety profile of AXL1717 in Phase I/II in cancer patients …
|
English | 20.9 KB | ||
| 2011-09-23 08:30 |
Dilaforette inleder fas I/II-studie med Sevuparin för behandling av svår malaria
|
Swedish | 147.9 KB | ||
| 2011-09-23 08:30 |
Dilaforette initiates a Phase I/II study with Sevuparin for the treatment of se…
|
English | 148.3 KB | ||
| 2011-09-01 08:45 |
Michael Sundström utsedd till Vice President Discovery Research för Karolinska …
|
Swedish | 220.5 KB | ||
| 2011-09-01 08:45 |
Michael Sundström appointed as Vice President Discovery Research of Karolinska …
|
English | 222.6 KB | ||
| 2011-08-25 00:00 | Swedish | 1006.9 KB | |||
| 2011-08-25 00:00 | English | 786.0 KB | |||
| 2011-08-22 15:37 |
Karolinska Development - Delårsrapport januari - juni, inbjudan till telefonkon…
|
Swedish | 198.9 KB | ||
| 2011-08-22 15:37 |
Karolinska Development - Interim report January - June, conference call Thursda…
|
English | 200.2 KB | ||
| 2011-07-07 09:00 |
Axelar rapporterar avslutad säkerhetsstudie i fas I/II med AXL1717 för cancerpa…
|
Swedish | 145.6 KB | ||
| 2011-07-07 09:00 |
Axelar reports completion of the Phase I/II safety study with AXL1717 in cancer…
|
English | 119.5 KB |
Automate Your Workflow. Get a real-time feed of all Karolinska Development filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karolinska Development
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karolinska Development via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-04 | Johan Dighed | Other | Buy | 35,000 | 56,350.00 SEK |
| 2023-03-27 | Johan Dighed | Other | Buy | 50,000 | 89,000.00 SEK |
| 2023-02-17 | Hans Christopher Karl Osvald Perbandt Toll | Other | Buy | 35,000 | 72,100.00 SEK |
| 2022-12-19 | Johan Dighed | Other | Buy | 50,000 | 83,500.00 SEK |
| 2022-09-30 | Johan Dighed | Other | Buy | 40,187 | 72,336.60 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,014 | 25,780.04 SEK |
| 2020-06-26 | Hans Lennart Rudolf Wigzell | Other | Buy | 5,000 | 14,350.00 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 9,276 | 26,529.36 SEK |
| 2020-06-24 | Hans Lennart Rudolf Wigzell | Other | Buy | 4,645 | 13,331.15 SEK |
| 2020-06-23 | Hans Lennart Rudolf Wigzell | Other | Buy | 39,702 | 111,562.62 SEK |
Peer Companies
